Target intelligence / Profile preview

Bacterial cell membrane phospholipids and anionic surface components

Molecular classification
Other
01

Overview

The bacterial cell membrane, specifically its phospholipids and anionic surface components, is a critical therapeutic target due to its essential role in maintaining cellular homeostasis and its distinct composition compared to eukaryotic membranes (Source 1.2.1, 1.5.3). In Gram-positive bacteria, the membrane is characterized by high levels of anionic phospholipids such as phosphatidylglycerol (PG) and cardiolipin (CL), along with lipoteichoic acids (Source 1.1.1, 1.2.2). Gram-negative bacteria feature an outer membrane dominated by lipopolysaccharides (LPS) and an inner membrane with a high proportion of anionic lipids (Source 1.3.3, 1.3.5). These negatively charged components facilitate the selective binding of cationic antimicrobial agents, such as polymyxins and daptomycin, through electrostatic interactions (Source 1.3.2, 1.4.1). Upon binding, these drugs disrupt the membrane's structural integrity, causing depolarization, pore formation, and the rapid leakage of essential intracellular ions and molecules, ultimately leading to cell death (Source 1.3.1, 1.4.5). While highly effective against multidrug-resistant pathogens, targeting the bacterial membrane presents challenges, including potential toxicity to host cells and the development of resistance through modifications in lipid composition or surface charge (Source 1.2.4, 1.3.1).

Other names
Bacterial cell membraneBacterial cytoplasmic membraneBacterial lipid bilayerAnionic bacterial surfaceBacterial membrane lipids
02

Mechanism of action

Disruption of membrane integrity through electrostatic binding to anionic phospholipids and surface components, leading to depolarization, pore formation, and leakage of intracellular contents (Source 1.3.1, 1.4.5).

03

Biological functions

Cellular barrierStructural integrityPermeability regulationEnergy metabolismProtein anchoringOther
04

Disease associations

Infection
05

Safety considerations

Nephrotoxicity (Source 1.3.1)Neurotoxicity (Source 1.3.1)Myopathy (Source 1.2.2)Rhabdomyolysis (Source 1.2.2)Hemolysis (Source 1.5.4)
06

Interacting drugs

Polymyxin B

10 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC) (Source 1.1.4)Membrane depolarization (Source 1.4.5)Intracellular potassium leakage (Source 1.4.5)Lipidomic profile (Source 1.2.4)

Beyond the preview

Go deeper on Bacterial cell membrane phospholipids and anionic surface components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell membrane phospholipids and anionic surface components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call